Microbot Historical Income Statement
| MBOT Stock | USD 1.00 0.04 4.17% |
Historical analysis of Microbot Medical income statement accounts such as Other Operating Expenses of 14.3 M can show how well Microbot Medical performed in making a profits. Evaluating Microbot Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Microbot Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Microbot Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Microbot Medical is a good buy for the upcoming year.
Microbot |
About Microbot Income Statement Analysis
Microbot Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Microbot Medical shareholders. The income statement also shows Microbot investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Microbot Medical Income Statement Chart
Microbot Medical Income Statement is one of the three primary financial statements used for reporting Microbot's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Microbot Medical revenue and expense. Microbot Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Microbot Medical's Interest Expense is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 14.3 M in 2024, despite the fact that Operating Income is likely to grow to (9.4 M). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Microbot Medical. It is also known as Microbot Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most accounts from Microbot Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Microbot Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.At this time, Microbot Medical's Interest Expense is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 14.3 M in 2024, despite the fact that Operating Income is likely to grow to (9.4 M).
Microbot Medical income statement Correlations
Click cells to compare fundamentals
Microbot Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Microbot Medical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 84K | 68K | 76K | 43K | 106K | 100.7K | |
| Interest Expense | 103K | 80K | 44K | 131.3M | 151.0M | 158.5M | |
| Gross Profit | (84K) | (68K) | (76K) | (102K) | (106K) | (100.7K) | |
| Other Operating Expenses | 7.2M | 9.1M | 11.4M | 13.3M | 9.9M | 14.3M | |
| Operating Income | (7.2M) | (9.1M) | (11.4M) | (13.3M) | (9.9M) | (9.4M) | |
| Ebit | (7.2M) | (9.1M) | (11.4M) | (13.3M) | (9.9M) | (10.3M) | |
| Ebitda | (7.2M) | (9.0M) | (11.3M) | (13.2M) | (9.7M) | (10.2M) | |
| Cost Of Revenue | 84K | 68K | 76K | 102K | 106K | 100.7K | |
| Total Operating Expenses | 7.2M | 9.1M | 11.4M | 13.3M | 9.7M | 18.8M | |
| Income Before Tax | (7.2M) | (9.2M) | (11.3M) | (13.2M) | (10.7M) | (11.3M) | |
| Total Other Income Expense Net | (7K) | (80K) | 44K | 113K | (885K) | (840.8K) | |
| Net Income | (7.4M) | (9.2M) | (11.3M) | 104.8M | (10.7M) | (11.3M) | |
| Income Tax Expense | 103K | 80K | (44K) | (118M) | (106.2M) | (100.9M) | |
| Research Development | 3.0M | 3.4M | 6.2M | 7.7M | 5.6M | 9.5M | |
| Selling General Administrative | 4.0M | 5.6M | 5.1M | 5.4M | 4.1K | 3.9K | |
| Net Income From Continuing Ops | (7.3M) | (9.2M) | (11.3M) | (13.2M) | (10.6M) | (11.1M) | |
| Net Income Applicable To Common Shares | (7.2M) | (9.2M) | (11.3M) | (13.2M) | (15.1M) | (15.9M) | |
| Interest Income | 43K | 16K | 103K | 54K | 212K | 222.6K | |
| Net Interest Income | (103K) | (80K) | 44K | 54K | 212K | 222.6K | |
| Reconciled Depreciation | 84K | 68K | 76K | 102K | 104K | 80.0K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Microbot Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Microbot Medical's short interest history, or implied volatility extrapolated from Microbot Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Microbot Stock analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Microbot Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microbot Medical. If investors know Microbot will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Return On Assets (0.69) | Return On Equity (1.82) |
The market value of Microbot Medical is measured differently than its book value, which is the value of Microbot that is recorded on the company's balance sheet. Investors also form their own opinion of Microbot Medical's value that differs from its market value or its book value, called intrinsic value, which is Microbot Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microbot Medical's market value can be influenced by many factors that don't directly affect Microbot Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Microbot Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Microbot Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbot Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.